Viewing nowCrego 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
IlYang Pharmaceutical Co., Ltd.

MFDS item code 201400379 · Approved 2014.01.28 · Insurance code 641704650
Treatment of dyslipidemia, inhibition of the progression of atherosclerosis, and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct therapy in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are insufficient. It also helps lower cholesterol levels when administered in conjunction with dietary measures or other treatments for patients with homozygous familial hypercholesterolemia. It lowers total cholesterol and LDL-cholesterol levels, slowing the progression of atherosclerosis, and is particularly effective in pediatric patients with heterozygous familial hypercholesterolemia. It is also used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia, contributing to reduced risk of stroke, myocardial infarction, and revascularization procedures in middle-aged people with high-sensitivity C-reactive protein levels and cardiovascular risk factors. This drug is effectively used for various types of dyslipidemia and to reduce cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and should continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, the treatment goal, and the patient's response; the dose may be increased to a maximum of 20 mg per day. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. Maximum daily dose: 20 mg. (There are no clinical data on doses greater than 20 mg in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, it should not be administered to individuals who are allergic to it, have severe liver impairment, have muscular disorders, have very poor kidney function, or are pregnant or nursing. Additionally, it should be used cautiously in patients at high risk for muscle damage or those taking certain medications together. Since this medication can affect liver function and muscle condition, regular liver enzyme and muscle-related tests should be conducted before and during treatment. Various side effects may occur, including muscle pain, weakness, fatigue, rash, indigestion, and headache, and if severe muscle damage or liver injury is suspected, use of the medication should be stopped immediately and medical consultation sought. This medication can interact with other drugs, so it is important to inform your healthcare provider about any concurrent medications, especially when taking specific antiviral medications, immunosuppressants, antifungals, antibiotics, and fibrate class drugs. Women of childbearing potential should use appropriate contraception before taking this medication and should avoid it during pregnancy. Nursing mothers are also advised against using this medication. In case of overdose, there is no specific antidote; treatment should be provided according to symptoms, and liver function and muscle enzyme levels should be monitored. Caution is advised when driving or operating machinery during treatment, as dizziness may occur.
Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug-induced erythema multiforme, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, AST elevation, joint pain, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius. Therefore, to maintain the effectiveness of the medication and prevent degradation, keep it in a cool and dry place.
Pink round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
IlYang Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.